Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction ∗

[1]  Harlan M. Krumholz,et al.  Sex-Based Differences in Early Mortality after Myocardial Infarction , 1999 .

[2]  F Van de Werf,et al.  Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. , 1999, The New England journal of medicine.

[3]  A. Moss,et al.  Thrombogenic factors and recurrent coronary events. , 1999, Circulation.

[4]  N. Ossei-Gerning,et al.  Sex Differences in Coagulation and Fibrinolysis in Subjects with Coronary Artery Disease , 1998, Thrombosis and Haemostasis.

[5]  Fowkes,et al.  Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants , 1998, British journal of haematology.

[6]  P. de Knijff,et al.  Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. , 1998, The New England journal of medicine.

[7]  A. Folsom,et al.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.

[8]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[9]  U. Goldbourt,et al.  Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study. , 1995, Journal of clinical epidemiology.

[10]  H. Krumholz,et al.  Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? , 1995, Circulation.

[11]  P. Ridker,et al.  Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.

[12]  G. Assmann,et al.  Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  A. Folsom,et al.  Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis , 1993, Thrombosis and Haemostasis.

[14]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[15]  J. Fleiss,et al.  Detection and Significance of Myocardial Ischemia in Stable Patients after Recovery from an Acute Coronary Event , 1993 .

[16]  J. Fleiss,et al.  Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter Myocardial Ischemia Research Group. , 1993, JAMA.

[17]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation , 1993 .

[18]  I. Godsland,et al.  Influence of age and menopause on serum lipids and lipoproteins in healthy women. , 1993, Atherosclerosis.

[19]  J. Jansson,et al.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. , 1991, British heart journal.

[20]  M. Fujimaki,et al.  Measurements of Crosslinked Fibrin Degradation Products , 1991 .

[21]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[22]  A. Maseri,et al.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.

[23]  E. Gilpin,et al.  Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. , 1988, The American journal of cardiology.

[24]  M. Alessi,et al.  Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.

[25]  M. Blombäck,et al.  PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.

[26]  C. Francis,et al.  INCREASED PLASMA CONCENTRATION OF CROSSLINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL INFARCTION , 1987, Thrombosis and Haemostasis.

[27]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[28]  D. Rylatt,et al.  Measurement of Crosslinked Fibrin Degradation Products – An Immunoassay Using Monoclonal Antibodies , 1983, Thrombosis and Haemostasis.

[29]  H. Weiss,et al.  Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. , 1983, The Journal of laboratory and clinical medicine.

[30]  T. Meade,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE , 1981, The Lancet.

[31]  Oxon Dm.  Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[32]  V. Marder,et al.  CLINICAL ASPECTS OF CONGENITAL FACTOR VII DEFICIENCY. , 1964, The American journal of medicine.

[33]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .